치과연부 조직 재생 시장 - 세계 및 지역별 분석 : 제품 유형별, 용도별, 최종사용자별, 지역별 - 분석 및 예측(2025-2035년)

Global Dental Soft-tissue Regeneration Market, Analysis and Forecast: 2025-2035

Dental soft-tissue regeneration is a medical process aimed at restoring or regenerating the soft tissues in the oral cavity, such as the gums, periodontal ligaments, and mucous membranes.

This regenerative treatment focuses on promoting the natural healing and regeneration of tissues that have been damaged or lost due to conditions like gum disease (periodontitis), trauma, or following dental procedures such as tooth extractions or implants. The process is essential for maintaining the functional health and aesthetic appearance of the oral cavity. Soft-tissue regeneration plays a crucial role in preventing gum recession, supporting dental implant placement, and restoring the appearance of the gums, especially when there has been significant tissue loss.

Techniques used in dental soft-tissue regeneration include gum grafting, platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, biomaterials, laser therapy, and ongoing research into stem cell therapies. This area of regenerative dentistry is increasingly important in periodontal disease management and implantology, where healthy, robust soft tissue is crucial for the long-term success of dental treatments.

One of the primary drivers of the Dental Soft-Tissue Regeneration market is the rising prevalence of periodontal diseases, such as gum recession and periodontitis. As these conditions become more widespread globally, there is an increasing demand for effective treatments to regenerate lost gum tissue, restore oral health, and improve aesthetics. Periodontal disease, which affects a significant portion of the population, often leads to the deterioration of gum tissues and can result in tooth loss if left untreated.

The need to address these issues, coupled with the growing awareness of the importance of maintaining healthy gums for overall oral health, is fueling the demand for soft-tissue regeneration procedures. Additionally, the aging population and the rise in dental implant procedures further contribute to this growth, as healthy, regenerated gum tissue is essential for the success and longevity of implants.

Despite the growth of the Dental Soft-Tissue Regeneration market, several challenges persist. One of the primary challenges is the high cost of procedures and materials. Regenerative treatments, including gum grafting, platelet-rich plasma (PRP) therapies, and advanced biomaterials, often involve significant costs.

These costs can be prohibitive for many patients, especially when insurance coverage is limited or unavailable. Additionally, the complexity of the procedures, the need for specialized training, and the requirement for high-quality materials add to the overall expense, making these treatments less accessible to a broader patient base. This financial barrier remains one of the key obstacles to the widespread adoption and growth of soft-tissue regeneration techniques in the dental industry.

The global Dental Soft-Tissue Regeneration market is indeed highly competitive, with numerous prominent players shaping the industry's growth and innovation. Companies like Dentsply Sirona, Geistlich Pharma AG, Institut Straumann AG, Tissue Regenix, Septodont Holding, Regedent AG, Advanced Medical Solutions Group PLC, Regenity, ZimVie Inc., and Henry Schein, Inc. are driving the development of advanced solutions in soft-tissue regeneration.

These companies are investing heavily in research and development, expanding their product portfolios, and forming strategic partnerships to enhance their competitive edge. Their efforts are focused on improving biomaterials, regenerative technologies, and minimally invasive procedures to meet the growing demand for effective soft-tissue restoration.

By offering a wide range of cutting-edge products and addressing the diverse needs of dental professionals and patients, these companies are contributing significantly to the market's evolution. As the demand for personalized and effective soft-tissue regeneration solutions increases, these industry leaders are poised to play a critical role in shaping the future of dental care.

Dental Soft-tissue Regeneration Market Segmentation:

Segmentation 1: by Product Type

• Autografts
• Synthetic Biomaterials
• Collagen-Based Membranes
• Others

Segmentation 2: by Application

• Implantology
• Periodontology
• Others

Segmentation 3: by End User

• Dental Hospitals
• DSO's & Independent Clinics
• Academic & Research Institutions

Segmentation 4: by Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

One of the most significant emerging trends in the global Dental Soft-Tissue Regeneration market is the increasing adoption of minimally invasive techniques. Patients and dental professionals are increasingly favoring treatments that involve smaller incisions, shorter recovery times, and less discomfort, which is driving the demand for laser therapy, microsurgical techniques, and biomaterial-based treatments.

These advancements allow for more precise interventions, reduce post-operative complications, and improve patient satisfaction. Moreover, the use of regenerative technologies such as Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), and stem cell therapies is gaining traction, as they offer potential for accelerated healing and tissue regeneration. This shift towards minimally invasive and regenerative treatments is significantly enhancing the effectiveness and appeal of soft-tissue regeneration in dentistry, especially in periodontal care and implantology.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Dental Soft-tissue Regeneration Market: Industry Outlook

• 1.1 Introduction
• 1.2 Market Trends
• 1.3 Regulatory Framework
• 1.4 Patent Analysis
• 1.5 Case Studies
• 1.6 Product Benchmarking
• 1.7 Market Dynamics
  • 1.7.1 Impact Analysis
  • 1.7.2 Market Drivers
  • 1.7.3 Market Challenges
  • 1.7.4 Market Opportunities

2. Global Dental Soft-tissue Regeneration Market (by Product Type), ($Billion), 2024-2035

• 2.1 Autografts
• 2.2 Synthetic Biomaterials
• 2.3 Collagen-Based Membranes
• 2.4 Others

3. Global Dental Soft-tissue Regeneration Market (by Application), ($Billion), 2024-2035

• 3.1 Implantology
• 3.2 Periodontology
• 3.3 Others

4. Global Dental Soft-tissue Regeneration Market (by End User), ($Billion), 2024-2035

• 4.1 Dental Hospitals
• 4.2 DSO's & Independent Clinics
• 4.3 Academic & Research Institutions

5. Global Dental Soft-tissue Regeneration Market (by Region), ($Billion), 2024-2035

• 5.1 North America
  • 5.1.1 Key Findings
  • 5.1.2 Market Dynamics
  • 5.1.3 Market Sizing and Forecast
    • 5.1.3.1 North America Dental Soft-tissue Regeneration Market, by Country
      • 5.1.3.1.1 U.S.
      • 5.1.3.1.2 Canada
• 5.2 Europe
  • 5.2.1 Key Findings
  • 5.2.2 Market Dynamics
  • 5.2.3 Market Sizing and Forecast
    • 5.2.3.1 Europe Dental Soft-tissue Regeneration Market, by Country
      • 5.2.3.1.1 Germany
      • 5.2.3.1.2 U.K.
      • 5.2.3.1.3 France
      • 5.2.3.1.4 Italy
      • 5.2.3.1.5 Spain
      • 5.2.3.1.6 Rest of the Europe
• 5.3 Asia Pacific
  • 5.3.1 Key Findings
  • 5.3.2 Market Dynamics
  • 5.3.3 Market Sizing and Forecast
    • 5.3.3.1 Asia Pacific Dental Soft-tissue Regeneration Market, by Country
      • 5.3.3.1.1 China
      • 5.3.3.1.2 Japan
      • 5.3.3.1.3 India
      • 5.3.3.1.4 Australia
      • 5.3.3.1.5 Rest of Asia Pacific
• 5.4 Rest of the World
  • 5.4.1 Key Findings
  • 5.4.2 Market Dynamics
  • 5.4.3 Market Sizing and Forecast

6. Global Dental Soft-tissue Regeneration Market: Competitive Landscape and Company Profiles

• 6.1 Key Strategies and Development
  • 6.1.1 Mergers and Acquisitions
  • 6.1.2 Synergistic Activities
  • 6.1.3 Business Expansions and Funding
  • 6.1.4 Product Launches and Approvals
  • 6.1.5 Other Activities
• 6.2 Company Profiles
  • 6.2.1 Dentsply Sirona
    • 6.2.1.1 Overview
    • 6.2.1.2 Top Products / Product Portfolio
    • 6.2.1.3 Top Competitors
    • 6.2.1.4 Target Customers/End-Users
    • 6.2.1.5 Key Personnel
    • 6.2.1.6 Analyst View
  • 6.2.2 Geistlich Pharma AG
    • 6.2.2.1 Overview
    • 6.2.2.2 Top Products / Product Portfolio
    • 6.2.2.3 Top Competitors
    • 6.2.2.4 Target Customers/End-Users
    • 6.2.2.5 Key Personnel
    • 6.2.2.6 Analyst View
  • 6.2.3 Institut Straumann AG
    • 6.2.3.1 Overview
    • 6.2.3.2 Top Products / Product Portfolio
    • 6.2.3.3 Top Competitors
    • 6.2.3.4 Target Customers/End-Users
    • 6.2.3.5 Key Personnel
    • 6.2.3.6 Analyst View
  • 6.2.4 Tissue Regenix
    • 6.2.4.1 Overview
    • 6.2.4.2 Top Products / Product Portfolio
    • 6.2.4.3 Top Competitors
    • 6.2.4.4 Target Customers/End-Users
    • 6.2.4.5 Key Personnel
    • 6.2.4.6 Analyst View
  • 6.2.5 Septodont Holding
    • 6.2.5.1 Overview
    • 6.2.5.2 Top Products / Product Portfolio
    • 6.2.5.3 Top Competitors
    • 6.2.5.4 Target Customers/End-Users
    • 6.2.5.5 Key Personnel
    • 6.2.5.6 Analyst View
  • 6.2.6 Regedent AG
    • 6.2.6.1 Overview
    • 6.2.6.2 Top Products / Product Portfolio
    • 6.2.6.3 Top Competitors
    • 6.2.6.4 Target Customers/End-Users
    • 6.2.6.5 Key Personnel
    • 6.2.6.6 Analyst View
  • 6.2.7 Advanced Medical Solutions Group PLC
    • 6.2.7.1 Overview
    • 6.2.7.2 Top Products / Product Portfolio
    • 6.2.7.3 Top Competitors
    • 6.2.7.4 Target Customers/End-Users
    • 6.2.7.5 Key Personnel
    • 6.2.7.6 Analyst View
  • 6.2.8 Regenity
    • 6.2.8.1 Overview
    • 6.2.8.2 Top Products / Product Portfolio
    • 6.2.8.3 Top Competitors
    • 6.2.8.4 Target Customers/End-Users
    • 6.2.8.5 Key Personnel
    • 6.2.8.6 Analyst View
  • 6.2.9 ZimVie Inc.
    • 6.2.9.1 Overview
    • 6.2.9.2 Top Products / Product Portfolio
    • 6.2.9.3 Top Competitors
    • 6.2.9.4 Target Customers/End-Users
    • 6.2.9.5 Key Personnel
    • 6.2.9.6 Analyst View
  • 6.2.10 Henry Schein, Inc.
    • 6.2.10.1 Overview
    • 6.2.10.2 Top Products / Product Portfolio
    • 6.2.10.3 Top Competitors
    • 6.2.10.4 Target Customers/End-Users
    • 6.2.10.5 Key Personnel
    • 6.2.10.6 Analyst View

7. Research Methodology